The Vanguard Group Discloses Stake in Mural Oncology

The Vanguard Group, Inc. has recently submitted a disclosure form 8.3 to the Irish Takeover Panel. This filing concerns Mural Oncology plc, of which Vanguard holds a significant position. As of August 20, 2025, Vanguard controls 771,683 ordinary shares, accounting for 4.47% of Mural Oncology's relevant securities.

The form indicates that Vanguard has made no additional disclosures related to other parties involved with Mural Oncology. Furthermore, no cash-settled derivatives or stock-settled derivatives have been declared in connection to Mural's securities. In terms of recent transactions, Vanguard sold 48 $0.01 ordinary shares at a unit price of 2.09 USD.

There are no indemnity agreements or options arrangements noted in this disclosure. The document confirms no extra forms were attached, and no additional agreements or understandings are linked to the disclosed securities.